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Our understanding of Parkinson’s disease (PD) has been revolutionized by the discovery of disease-causing
genetic mutations. The most common of these is the G2019Smutation in the LRRK2 kinase gene, which leads
to increased kinase activity. However, the link between increased kinase activity and PD is unclear.
Previously, we showed that dopaminergic expression of the human LRRK2-G2019S transgene in flies led to
an activity-dependent loss of vision in older animals and we hypothesized that this may have been preceded
bya failure to regulateneuronalactivitycorrectly inyoungeranimals.To test thishypothesis,weusedasensitive
measureofvisual functionbasedonfrequency-taggedsteady-statevisuallyevokedpotentials.Spectralanalysis
allowed us to identify signals frommultiple levels of the fly visual system and wild-type visual response curves
were qualitatively similar to those from human cortex. Dopaminergic expression of hLRRK2-G2019S increased
contrast sensitivity throughout the retinal network. To testwhether thiswas due to increased kinase activity, we
fed Drosophilawith kinase inhibitors targeted at LRRK2. Contrast sensitivity in both day 1 and day 14 flies was
normalized by a novel LRRK2 kinase inhibitor ‘BMPPB-32’. Biochemical and cellular assays suggested that
BMPPB-32 would be a more specific kinase inhibitor than LRRK2-IN-1. We confirmed this in vivo, finding that
dLRRK2 null flies show large off-target effects with LRRK2-IN-1 but not BMPPB-32. Our data link the increased
Kinase activity of the G2019S-LRRK2 mutation to neuronal dysfunction and demonstrate the power of the
Drosophila visual system in assaying the neurological effects of genetic diseases and therapies.
INTRODUCTION
Although the primary deficits in Parkinson’s disease (PD) are
related to rigidity, postural instability, bradykinesia and tremor,
a wide variety of visual issues have also been reported—ranging
from abnormal light adaptation to visual hallucinations (1). The
discovery that dopamine plays an active part in signal regulation
in the human retina (2,3), and that retinal dopamine is reduced
in PD (4), means that some of the visual consequences of PD
may originate in the retina—the earliest and most fundamental
stage of visual processing.
Oneproblemwithassayingvisual deficits inhumanParkinson’s
patients is that this is aheterogeneousdiseasewithmultiplegenetic
and environmental origins. A powerful complement to this ap-
proach is to dissect the complex neural deficits using the genetic-
ally tractable model organism, Drosophila. Although flies are
only distantly related to humans in evolutionary terms, many of
the neuronal circuits in the vertebrate and fly eye appear to be
analogous. This was first noted by Ramon y Cajal using silver
staining (5) and it has been confirmed bymoremodern cytochem-
ical tools (6). Crucially, both vertebrates and flies have dopamin-
ergic neurons in the visual system (7,8) and dopaminergic
circuits modulate fly vision (9,10). It is therefore possible that
PD-associated pathogenic mutations may have similar effects on
very early visual processing in both flies and humans.
Here, we focus on a single nucleotide polymorphism in the
LRRK2gene (G2019S).This is carriedby a relatively largepropor-
tion of human PD patients, 3–40%, depending on ethnicity (11),
making it the most common genetic cause of PD. Nonetheless,
the role of the LRRK2 protein in the pathogenesis of PD
is unclear (12). Manipulations of LRRK2 in mouse have not gen-
erated robust neuronal phenotypes (13), with the most marked
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responses suggesting abnormal kidney function (14). However,
expressing a range of LRRK2 transgenes in the fly has revealed
mitochondrial and synaptic phenotypes (15–17). Recently, our
group (9) showed a highly selective response to LRRK2-G2019S
expression in fly dopaminergic neurons: a loss of visual response
and degeneration of the retina in old flies. This was not seen with
the expression of wild-type hLRRK2 or other hLRRK2mutations.
What leads to this loss of visual function?We showed that the
degeneration was accelerated by increased neuronal activity (9)
and hypothesized that young G2019S flies could be shown
to have amplified neuronal response, if only a more sensitive
assay were available. In human visual electrophysiology, the
steady-state visual evoked potential (SSVEP) method is a sensi-
tive technique that is often used to measure neuronal response
amplitudes in both adults and more challenging populations
such as infants. In the SSVEP assay, responses to flickering
patterns are routinely recorded by an array of electrodes and
their signals used to compute the visual sensitivity. Sensitivity
is high because responses to many hundreds of stimulus events
are averaged together and out-of-band noise is eliminated from
the analysis. In this article,wedevelop anSSVEPassay forDros-
ophila retina and show it is sensitive enough to demonstrate that
one-day-old flies expressing LRRK2-G2019S in their dopamin-
ergic neurons already have abnormal visual neurotransmission.
A similar approach has been used to examine the processing of
visual signals in the fly brain (18–20).
The discovery (in biochemical assays) that the G2019S muta-
tion increases the kinase activity of LRRK2 (21) has led to the
development of several potential kinase inhibitors that may
provide the basis for novel therapeutic approaches. These could
potentially be of great value, as the current symptomatic PD treat-
ment by L-DOPA is time-limited and does not delay disease pro-
gression.We thereforeusedournovelSSVEPassay todoa ‘first in
vivo’ test of two kinase inhibitors targeted at LRRK2.One inhibi-
tor ‘BMPPB-32’ is a newLRRK2 reference compound character-
ized by high specificity and selectivity to the LRRK2 kinase
domain (see Supplementary Material, Material and Methods).
The other compound, ‘LRRK2-IN-1’, is a leading LRRK2
kinase inhibition reagent in biochemical assays, first described
in ref. (22).Wefind that both compounds ameliorate the abnormal
visual phenotypes associated with the G2019S mutation.
Finally, the ideal therapeutic compound should be specific for
thekinasedomainofLRRK2,andnotaffectotherkinases.Achiev-
ing this selectivity is possible but challenging because of themore
or less conserved nature of the ATP-binding pocket in vertebrate
kinases. To test our compounds for non-specific kinase effects,
we applied them to the dLRRK2 null fly and used the sensitive
SSVEP assay to show that LRRK2-IN-1 has stronger off-target
effects than BMPPB-32. Our SSVEP approach therefore high-
lights the possibilities of theDrosophilavisual systemas an effect-
ive model for genetic and therapeutic analysis of visual responses
related to human vision.
RESULTS
Contrast-driven SSVEP responses in Drosophila
We recorded the response of the fly visual system to a pre-
programmed sequence of frequency-tagged flickering stimuli
Figure1.Recordingandanalysing thevisual responsewithSSVEP. (A) Fliesare restrained in aGilsonpipette tip and illuminatedbyablue, light-emittingdiode (LED)
is driven with by a continuously flickering wave. Electrodes on the eye and mouth record the response of the visual network. The signal is amplified and digitized.
(B) The stimulus is the sum of 2 square waves (1F1 and 1F2). (C) A typical recording, showing 1 s of data from a single trial in one white-eyed fly. (D) The response
is separatedout into its separate parts by frequency. In this experiment, the stimulushad two input frequencies (12 and15 Hz).Harmonics of the inputs are shown in the
Fourier transform of the signal as green bars. Low-order intermodulation terms (e.g. 1F2-1F1, 2F1+2F2) are shown in brown. (E) Responses at any given frequency
have a complex phase as well as an amplitude. This can be illustrated in a polar plot where amplitude is mapped along the radial direction and decreasing angle in the
clockwise direction indicates increasing phase lag. Here, the response to a 60% contrast measured at 1F1 in amutant phenotype is illustrated. The shaded circle indi-
cates the complex standard error of the mean computed across individual flies. (F) Diagram of the structure of the fly visual system. This includes the photoreceptors
and the second-order amacrine (A) and lamina neurons (L1, L2). It also shows two types ofmedulla neurons (C and T) that project to the lamina. The visual lobes also
include dopaminergic cells (DA), some intrinsic to the medulla, others projecting from the CNS to the lamina. For each category of neuron, only one or two repre-
sentative cells are shown. Diagram based on silver staining (23) and dopaminergic reporters (9).
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(Fig. 1). This type of stimulus is commonly used in electrophysio-
logical experiments because it generates frequency- and phase-
locked response components with a very high signal-to-noise
ratio (19,20,24–28). Our first goal is to understand how the re-
sponse relates to neural activity in each of the components of
the visual pathway (Fig. 1F). In Drosophila, the response is
mediated by the retinal photoreceptors which synapse onto the
second-order neurons. Some second-order neurons, the amacrine
cells, mediate lateral interactions in the network, but the main
lamina neurons project to the third-order cells in the medulla.
Since the retinal, lamina andmedullaneurons are effectively elec-
trically linked in series (29), all of these neuronsmay contribute to
the waveform. The responses from these different stages can, in
theory, be disambiguated by the different components they gener-
ate in the frequency domain, and this can be confirmed by genetic
dissection of the retinal network.
In SSVEPexperiments, each frequency-tagged stimulus com-
ponent with a fundamental frequency of F generates a set of
peaks atmultiples of F. For example, in Figure 1D, the responses
to the input components at 12 and 15 Hz are evident at 12, 15, 24
and 30 Hz. These are coded in green. In this article, we adopt the
nomenclature used in previous papers (27,30) when referring to
frequency components: each component is identified by the code
[harmonic]F[input]where [input] indexes thedifferent input cat-
egories (1 ¼ probe, 2 ¼ mask) and [harmonic] indicates the
multiple of each input fundamental. For example, the component
corresponding to the second harmonic of the ‘probe’ component
is 2F1, while the third harmonic of the ‘mask’ component would
be 3F2.
The largest responses to the inputs are typically found at the
first and second harmonics: ‘1F’ and ‘2F’. For the first input
frequency component that we call the ‘probe’, these frequencies
correspond to 12 and 24 Hz (‘1F1’ and ‘2F1’).
Signals that respect the polarity of the input can be thought of
as weighted Fourier components of the square wave that we use
to drive the photoreceptors. These include the first harmonic
(1F), and other ‘odd multiple’ harmonics at 3F, 5F, 7F and so
on. They must result from an asymmetric response to the light
onset and offset and it is most likely that their primary source
is the sustained photoreceptor depolarization event elicited by
the onset of the periodic light pulse. ‘Even’ harmonics (2F, 4F,
6F, . . .) on the other handmust be generated by ‘symmetrical’ re-
sponse to either the onset or the offset of light and we therefore
propose that their origin lies in the responses of the second-order
lamina cells which generate the transient responses that accom-
pany the on- and off-transients of traditional electroretinograms.
Finally, responses at low-order sums and differences of the
input frequencies must arise from non-linear combinations of
the inputs (31,32). These responses (e.g. 2F1+2F2) are most
likely to arise from interactions of the lamina and medulla
neurons, where non-linear operations such as rectification or
divisive normalization at higher levels of visual processing
may occur. It is also possible that they derive from a non-linear
transducer stage in the retina.
Isolation of photoreceptor and neuronal responses
To test these hypotheses about the physiological origins of
the harmonic signature in SSVEP responses, we used genetic
knockouts to isolate individual processing stages. The ort2/2
knockout mutation inactivates the histamine A receptors on
the second-order lamina neurons, thereby preventing photo-
receptor  lamina and photoreceptor  amacrine cell signal-
ling (33). The effect of this mutation is very clear in an SSVEP
analysis (Fig. 2), where we compare wild-type (wt) and ort2/2
flies. The 1F1 components in wild-type flies (Fig. 2Ai) are mod-
erately reduced in this ortmutant (Fig. 2Aii and iii): at the high
end of the contrast range, they are approximately half the wild-
type. This reduction in the 1F1 responses may result from the
fact that we have abolished the feedback loop from the laminar
neurons and amacrine cells that normally regulates photorecep-
tor function (34).
However, the 2F1 (Fig. 2Bi) responses are almost completely
eliminated in the ort2/2 flies (Fig. 2Bii and iii)—as would
be expected if they were a result of transient synaptic firing. The
2F1 response in these ortmutants is only evident at high contrast,
where it is ≏20% of the wild-type, though significantly (one-tail
t-test,P, 0.05) above the system noise (Fig. 2Biii). This residual
response could arise from a number of sources. Most likely, it
derives from the small on- and off-transients in the polarization/
depolarization cycle inherent to the photoreceptors themselves
[as shown in intracellular photoreceptor recordings, e.g. (35)]. It
is also possible that transmission can occur through other, indirect
routes (e.g. other types of histamine receptors or gap junctions). A
last possibility that this ortmutation does not block photoreceptor
output completely seems unlikely based on previous recordings
(33). The data from Figure 2 indicate that a significant fraction
of the second harmonic response originates from neuronal signal-
ling mechanisms and synaptic transmission rather than from the
photoreceptors.
Finally, the fourth-order intermodulation term 2F1+2F2 is
entirely abolished, with the level of the signal similar to the
system noise (Fig. 2C). This suggests that the 2F1+2F2 signal-
ling is entirely neuronal.
Thus, the 2F1 and 2F1+2F2 components depend on synaptic
transmitter release by the photoreceptors and so these compo-
nents indicate signalling downstream of the sensory neurons.
This is encouraging because it allows us to make direct compar-
isons between neuronal data in flies and vertebrates (particularly
humans).
Contrast response functions in Drosophila
We designed our experiments to deliver stimuli similar to those
used in earlier human and animal work. These stimuli sweep
through different contrast levels, allowing us to measure and
analyse population-level contrast versus response functions
(CRFs). The measurement of these CRFs is important. Sensory
neurons must adjust their sensitivity in order to ensure that
they signal changes in the environment efficiently. To achieve
this, they scale their sensitivity by a factor related to the
average amplitude of the local spatiotemporal input. This ‘nor-
malization’ appears to be a canonical computation that is also
found across different parts of the central nervous system and
in a wide variety of different organisms (36). When this multi-
plicative scaling is applied to the input stage, it results in a stereo-
typical rightward shift of the logarithmic input versus output
function of the neuron that has been observed in a wide variety
of experiments (25,27,37–41). In addition, some systems also
demonstrate ‘response gain’: a scaling of the outputs rather
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than the inputs, resulting in a downward compression of the
response versus contrast curve. It has been observed that both
types of gain control can result from a single type of multiplica-
tive input modulation with differences between contrast and
response gain control arising from differences in the size and
specificity of the gain pool (42).
In the Drosophila experiments described here, we therefore
swept the temporal contrast of the ‘probe’ stimuli through a
range of values (0–69%) and measured responses to these
stimuli both in isolation, and in the presence of a 30% contrast
mask at a different temporal frequency. Performing the experi-
ments using ‘frequency tagging’ in this manner allows us to
measure the effects of stimulus and mask contrast in isolation
even though they are superimposed in the stimulus. If theDros-
ophila nervous system exhibits the type of gain control found
in other organisms, we expect to see a reduction in the probe
response when the constant mask contrast is presented at the
same time.
Response versus contrast
RobustCRFs fromcontrol flies (white eyed,+, day 1) are shown
in Figure 3. Unmasked responses (shown in grey) from both the
first (1F1) and second (2F1) harmonic components of the swept
probe (Fig. 3Ai and ii, respectively) increasemonotonicallywith
contrast and we can measure reliable signal amplitudes over the
entirenon-zero contrast range.This high signal-to-noise ratio is a
feature of SSVEP recordings and derives from the fact that
hundreds of instances of each stimulus condition are averaged
together in a phase-sensitive manner and out-of-band noise
can be rejected entirely. Fitting a three-parameter hyperbolic
ratio function, as in human studies (25,43), provides a smooth
Figure 2. Separation of photoreceptor from neuronal signalling. Harmonic and intermodulation plots from control flies (wt, left column) and ort mutant flies (ort2/2,
right column). This ort mutation inactivates the histamine A receptor leading to an absence of photoreceptor  second-order neuron synaptic transmission. Flies
carrying this mutation exhibit moderately reduced first harmonic (F1) responses (A) but their second harmonic (2F1, B) and intermodulation terms (2F2+2F1, C)
are effectively abolished. We interpret this as evidence that the first harmonic is due primarily to on/off responses from the photoreceptors while the 2F1 and
2F2+2F1 terms are generated by neuronal signalling.N ¼ 17 (wt), 16 (ort); all flies have white eyes and were 1 day old. The solid line indicates the mean response,
with the shaded area as+1 standard error.
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curve that passes through themean data for both the 1F1 and 2F1
data points (Fig. 3B).
Masking and intermodulation
Whenamask contrast is applied at a different frequency (F2), the
response to the swept input probe changes. The grey curves show
the responses when the mask is absent and are therefore a base-
line; the red curves show the response measured in the presence
of a constant contrast (30%)mask as the probe contrast increases
from0 to69%(Fig. 3).Responses at 1F1, 2F1, 2F2+2F1and2F2
are shown in Figure 3Ai–iv, respectively, and the fitted hyper-
bolic ratio curves for 1F1 and 2F1 are shown in Figure 3B. The
parameters of the hyperbolic fits (Fig. 3C) show that the nature
of these changes is different at the 1F1 and 2F1 component fre-
quencies: in the 1F1 response (Fig. 3Bi), our fitting procedures
indicate a reduction in the both c50 (the semisaturation constant)
andRmax (themaximum response). In comparison, the change in
the 2F1 component is best modelled as a large change in Rmax
with no significant change in c50 (Fig. 3Cii). Masking at the
neuronal stage therefore manifests as almost a pure response
gain change in this phenotype.
The frequency spectrum obtained from a two-input experi-
ment also contains significant power at sums and differences
of the input frequencies. In our data (Fig. 3Aiii), these ‘intermo-
dulation’ responses are maximal around the point at which the
mask and probe contrast are equal (30% contrast)—a phenom-
enon also seen and modelled in our human data (30). When
the second input frequency is not present, the response at this
intermodulation term is, naturally, flat and gives an estimate of
baseline noise levels.
Finally, it is instructive to examine the response at the second
harmonic of the mask frequency 2F2 as the probe contrast
increases (Fig. 3Aiv). In all our experiments, we see the mask re-
sponse remaining relatively constant until the probe contrast
matches it. The mask response then declines relatively steeply as
the probe contrast increases further. Again, this ‘winner-take-all’
normalization is a feature of both human EEG and vertebrate
single unit experiments (25,30).
Aberrant responses in the TH>G2019Smodel of PD at day 1
We have shown that the SSVEP technique generates CRFs that
strongly resemble thoseofhumans, that the 1F1component repre-
sents photoreceptor signalling and that the 2F1 and 2F1+2F2 re-
present separate stagesof theneuronal response.Ourhypothesis is
that the degeneration seen in old flies expressing LRRK2-G2019S
was due to hyperactivity at an early age. Therefore, we next ask if
the SSVEP technique is powerful enough to reveal small changes
due to dopaminergic expression of the PD-related mutation
G2019S in the youngest flies, when they are 1 day old. We used
the tyrosine hydoxylase (TH) GAL4 (44) to drive expression of
either normal humanhLRRK2orhLRRK2-G2019S and compared
these with a cross between the GAL4 and wild-type flies (TH/+)
that do not express a human transgene. Data are displayed in three
figures: the raw data in Figure 4, the fitted curves in Figure 5 and
the phase data in Figure 6. Statistical analysis is given in Figure 8
and Table 1.
We find that neuronal responses in 1-day-old TH.hLRRK2
flies are largely similar to those in the TH/+ controls (Fig. 4).
However, we observe significant changes in the visual responses
of the TH.G2019S flies at this very early stage.
Most strikingly, the contrast sensitivity of the TH.G2019S
flies is increased dramatically. This results in a shift of the
unmasked CRFs relative to the TH.hLRRK2 and TH/+.
Because of this shift, the peak neuronal response (2F1 and 2F2)
is larger than that seen in controls. The shift in the input/output
curve induced by masking is also much larger (Fig. 4B).
TH.G2019S flies also show amuch larger fourth-order intermo-
dulation term (2F1+2F2, Fig. 4D), though the peak of the
Figure 3.Neural responses to swept contrast flicker inwild-type (wt)Drosophila closely resemble those fromhumandata. (A) Contrast response functions for (i) 1F1,
(ii) 2F1, (iii) 2F1+2F2with (red) andwithout (grey) a 30%maskas theprobe contrast is increased from0 to70%;while (iv) shows the amplitude of the2F2 response to
30%mask, as the probe contrast is increased. (B) Plots of the fitted hyperbolic ratio function {Rmax[c
n/(cn + cn50)]} for data in corresponding panels in (A). (C) The
estimated c50 andRmax formasked and unmasked data for the data shown in (Ai) and (Aii).Masking has little effect on the 1F1 response, but≏halvesRmax for the 2F1
response. In (A), the solid line indicates the mean response, with the shaded area as+1 standard error. Data from 6 one-day-old white-eyed flies.
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response still occurs when the contrast of the F2 stimulus compo-
nent is ≏30% of F1 contrast.
The increased sensitivity of TH.G2019S flies could result
from a change in either the Rmax or c50 parameter. Estimates
of these parameters will also provide the basis for statistical
comparison of genotypes and, later in the article, of drugs. We
therefore performed bootstrapped fits of the hyperbolic ratio
function to the TH.G2019S, TH.hLRRK2 and TH/+ data.
These fits show that the dopaminergic expression of the
PD-associated G2019S genetic variant affects both c50 and Rmax
for 1F1 and 2F1 (Fig. 5). The masked Rmax value for TH.
G2019S is larger than for the controls (TH.hLRRK2 and
TH/+) (P, 0.01), but the unmasked values of Rmax are similar
in all three genotypes. This suggests that the masked, but not the
unmasked Rmax parameter at 2F1 distinguishes between the phe-
notypes—most likely because many of the unmasked curves
simply fail to saturate at the contrast levels that we are using,
making estimates of maximum response level unreliable.
Figure 4. Abnormal visual signalling in 1-day-old flies expressing LRRK2-G2019S in their dopaminergic neurons (TH.G2019S, left hand column) compared
with those expressing wild-type human LRRK2 (TH.hLRRK2, middle column) or outcross controls (TH/+, right hand column). Contrast response functions
in the TH.G2019S flies are substantially steeper (A: 1F1 and B: 2F1), while the effect of the 30% mask is much stronger (C, 2F2). The intermodulation
term (2F1+2F2) is also substantially enhanced (D). Flies expressing the normal form of hLRRK2 in the dopaminergic neurons (TH.hLRRK2) show visual
signalling very close to the control (TH/+) flies. Parameter fits for this data are shown in Figure 5, and statistical tests are provided in Table 1. The contrast response
function in the presence of the second,masking, input is indicated by the pink shading. The solid lines indicate themean response; the shaded area+1 standard error.
N ¼ 9, 10, 11.
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The 1F1 c50 of both the unmasked and masked components is
reduced to ≏50% in TH.G2019S, compared with the control
flies. The variance is also smaller suggesting consistent differ-
ences between the TH.G2019S and control flies. Similarly,
the unmasked 2F1 c50 in TH.G2019S is reliably smaller than
in the TH.hLRRK2 and TH/+ controls. As the 2F1 component
originates from the second-order retinal neurons, we have used
this parameter in our statistical tests, and find the difference
between the unmaskedTH.G2019S andTH/+ is highly signifi-
cant at P , 0.01.
A second useful index of neuronal activity is the temporal
phase of the SSVEP response (Fig. 6). A common feature of
CRFs measured in both humans and animals is that response
phase advances with increasing stimulus contrast. This phase
advance is predicted by simple biophysical models of gain
control that treat sensory neurons as leaky integrators with a
contrast-dependent membrane impedance (28,45) Although
the phase of an SSVEP signal is related to temporal lags in the
signal transduction pathway, its interpretation is complicated
by the circular nature of the signal (phase advances and
phase lags cannot be disambiguated) and also by the fact that
changes in the shape of a complex evoked waveform can gener-
ate different phase lags in its constituent frequency components.
It is clear that significant phase shifts between theTH.G2019S
and TH/+ responses are present at certain frequencies. In
Figure6,weplot thephases andamplitudesof three representative
frequency components (1F1, 2F1 and 2F2) near their maxi-
mum amplitudes. For consistency, only data from the masked
Figure 5.Modelling of the contrast response functions confirms the abnormality of the visual response in 1-day-old TH.G2019S flies. Fitting the hyperbolic ratio
function forTH.G2019S,TH.hLRRK2andTH/+ for1F1 (A) and2F1 (B) providesestimatesofc50 (C) andRmax (D).Theseshowthat expressionofLRRK2-G2019S
in the dopaminergic neurons shifts the 1F1contrast response function to the leftwith both themasked andunmasked stimulation.However, the unmasked2F1contrast
response function shows a leftward shift but masking affects Rmax. Original data plotted in Figure 4, while statistical tests are provided in Figure 8 and Table 1.
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conditions (which contain both F1 and F2 components) are
plotted. Responses at 1F1 differ by just ,1/6 of a full stimulus
period (equivalent to 1/6 ∗ 1/F1 of a second or approximately
13 ms) with the TH.G2019S responses leading those from the
TH/+ controls (Fig. 6A). Responses at 2F1 differ by a little
more than a quarter of a cycle, yielding a phase lag for the
control animals of ≏12 ms (Fig. 6B). Similarly, we observe a
phase shift of slightly more than 1/4 of a cycle in the 2F2
responses. Because a single cycle of the 2F2 frequency (30 Hz)
is 1/30 s, this phase shift corresponds to a temporal difference
of ≏10 ms, but this estimate is less reliable because of the high
variance of the G2019S data at this frequency and the relatively
small magnitude of the control 2F2 response. These data
suggest that the reduced response latency of visual signals in
the TH.G2019S flies originates in the photoreceptors and is
inherited by the second-order laminar neurons.
In summary, we find that expression of LRRK2-G2019S in
dopaminergic neurons has an effect on both the photoreceptor re-
sponse (F1), and the neuronal signalling of both the second-order
lamina neurons (2F1) and of the neurons which generate the
2F1+2F2 signal (which we suggest is the lamina/medulla
system). Modelling suggests that the predominant effect is an in-
crease in both maximum masked response amplitude (Rmax) and
unmasked response sensitivity (c50) in the TH.LRRK2-G2019S
animals associated with a small reduction in response latency.
In old flies, SSVEP analysis shows a reduction in visual gain in
the TH.G2019S flies, as exemplified by the reduced 2F1 Rmax
(SupplementaryMaterial, Fig. S4). These both confirm our previ-
ous data collected using traditional flash electroretinograms (9),
and show that SSVEP detects both increased and decreased gain
in the TH.G2019S flies at young and old ages respectively.
The changes in visual response sensitivity that we observe
in flies carrying the TH.G2019S mutation appear to be a bio-
marker for this mutation. Biomarkers such as these are interest-
ing because they allow us to assay the effect of potential
therapeutic compounds targeted at the LRRK2 protein. The
G2019S mutation lies within the kinase domain of this protein,
rendering it constitutively active. We therefore asked whether
the biomarker we have identified in flies could be used to test a
novel class of candidate PD drugs that are specifically targeted
at the human LRRK2 kinase domain.
Kinase inhibitors restore wild-type CRFs
Previouswork has identified LRRK2-IN-1 (22) as a useful refer-
ence compound for LRRK2 kinase inhibition. We have now
synthesized BMPPB-32, a novel LRRK2 inhibitor identified
from the patent literature (Fig. 7A). Biochemical and cell-based
assays showpotent inhibitionof kinase activity of bothwild-type
and G2019S variants of hLRRK2. In a biochemical Lantha-
Screenw assay (Fig. 7B), BMPPB-32 inhibited hLRRK2 and
G2019S with apparent Ki’s of 1.5 and 6 nM, respectively. In
HEK293 cells, apparent IC50 values of BMPPB-32 on LRRK2
WT, the overactive variant G2019S and the LRRK2-IN-1
inhibition-resistant mutant A2016T were 34, 94 and 64 nM, re-
spectively (Fig. 7C). Profiling using large kinase panels suggests
that BMPPB-32 is a selective LRRK2 inhibitor at physiologically
relevant ATP concentrations, with good selectively for LRRK2
(Supplementary Material, Figs S1–S3, Results, Table S1). We
therefore applied 2.5mM BMPPB-32 throughout larval life,
finding that 1-day-old flies contained 37 ng BMPPB-32 pr. g fly
tissue. (Supplementary Material, Results). We then measured
the effects on the SSVEP responses on 1-day-old adult flies
which had been treated either with BMPPB-32 or LRRK2-IN-1.
Figure 8A shows the effects of these two kinase inhibitors on
the 2F1 components of the frequency-tagged responses in
TH.G2019S flies, in comparison with the wild-type (TH/+)
and untreated TH.G2019S. Whereas, as noted above, the
TH.G2019S has a much steeper CRF, with greater masking,
both kinase inhibitors restored the TH.G2019S CRF to a
shape similar to that of the control flies. Masking also appears
similar to control levels. Both LRRK2-IN-1 and BMPPB-32
affect the complete TH.G2019S phenotype (Fig. 8B, statistics
in Table 1), rescuing the photoreceptor (1F1) and neural re-
sponse (2F1+2F2). We also examined the effect of the kinase
inhibitors on the phase of the 1F1 responses, and found that
both drugs reverted the phase change of the TH.G2019S flies
(Fig. 8C).
We noted previously that the most salient effect of the
LRRK2-G2019S mutation was to increase the sensitivity of the
unmasked 1F1 and 2F1 responses and reduce themaximum amp-
litude of themasked response.The sensitivity changecorresponds
to a reduction in the semisaturation constant (c50)when the curves
Figure 6. The G2019S mutation changes the response phase of the SSVEP recording. The response lag of the SSVEP signal is shown in polar space with one full
cycle of the response corresponding to 2p radians (360 degrees). Lag increases clockwise. (A) TH.G2019S increases the amplitude of the second harmonic of
the first input (2F1) but has little effect on its phase. In comparison, the responses at 2F2 (B) and the intermodulation term 2F1+2F2 (C) are both larger and phase-
shifted with the dopaminergic expression of theG2019Smutation. Data from same 1-day-old flies as Figure 4. The one-wayMANOVA on the complex data shows
that all differences are significant atP, 0.05 except for the 2F2condition,Table 1.An analysis of the complexphase shows that all phase differences are significant at
P , 0.05.
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are fitted with a hyperbolic ratio function, while the amplitude
change corresponds to an increase in the Rmax parameter. In
Figure 8D, we plot these parameters (c50 for the unmasked 2F1
component, Rmax for the masked 2F1) for the four phenotypes
listed above. The reduction in c50 in the TH.G2019S animals
is highly significant, while no significant difference is observed
between the control (TH/+) and LRRK1-IN-1 drug-treated
animals, indicating that this kinase inhibitor is effective in restor-
ing wild-type neuronal sensitivity. Similar effects are measured
for theRmaxparameter.TheBMPPB-32kinase inhibitorhasquali-
tatively similar effects to LRRK2-IN-1with a statistically signifi-
cant restoration of Rmax and a near-significant increase in c50.
BMPPB-32 also reverts the loss of visual neuronal gain seen in
14-day-oldTH.G2019Sflies (SupplementaryMaterial, Fig. S4).
Off-target effects
Oneproblem in any drug assay is off-target effects. For example,
an inhibitor targeted at the kinase domain of one protein may
bind to other proteins that have similar kinase domain structure
thereby rendering its use as a therapeutic agent problematic.
Toexamine the potential off-target effects of the two compounds
tested above, we measured SSVEPs in dLRRK2 flies, in which
the homologous dLRRK gene has been knocked out. CRFs in
these flies resemble those of the TH/+ controls (compare
Fig. 9Ai and ii). The probe (2F1) and mask (2F2) responses
in the dLRRK2 flies resemble those of the outcross controls,
although the variance is slightly greater. When LRRK2-IN-1 is
applied, a severe change in phenotype is seen, with an increase
in amplitude of both signals (Fig. 9A and Biii) and strong
masking shift (Fig. 9Biii). This may indicate that LRRK2-IN-1
is binding toother kinases, perhaps those related to (mammalian)
MAPK7 or DCLK2 (22)—see also Supplementary Material,
Figures S1–S3 and Results. However with BMPPB-32, there
is no significant change in the CRFs in the dLRRK2 knockout
(Fig. 9A and Biv), suggesting this compound has no major off-
target effects affecting the SSVEP. This is consistent with the
clean kinase selectivity profile of BMPPB-32 in mammalian
cells (Supplementary Material, Figs S1–S3 and Results).
DISCUSSION
We have developed and applied the SSVEP technique to Dros-
ophila, measuring contrast-driven responses at multiple visual
processing stages. Neuronal responses measured in this manner
show an intriguing functional homology with those measured in
vertebrates.
Using these SSVEPmeasurements, we show that the presence
of a PD-related human transgene affects visual processing and
that such changes are reversible in vivo by drug treatment.
Functional homology
In most respects, our SSVEP data fromDrosophilamimic those
observed in other species. Our stimulation paradigms were
adapted directly from those used in humans (25,27,30,46) and
cats (25,28). As in these papers, we found that responses at the
probe frequency increased with contrast and exhibited multi-
plicative masking in the presence of a second, constant contrast
component. The response at the mask frequency exhibited a
non-linear ‘winner-take-all’ behaviour—remaining relatively
Figure7.BMPPB-32 structure andLRRK2kinase inhibition. (A)Chemical structure ofBMPPB-32. (B)BiochemicalKi values obtained in theLanthascreenLRRK2
activity assay using themammalian cell purified LRRK2WT andG2019S protein fromLife Technologies. (C) Cell-based LRRK2-pSer935 IC50 values obtained in
HEK293 cells transiently transfected with either wild-type LRRK2, the PD-relevant G2019S or the inhibition-resistant mutant A2016T.
Table 1. Statistical analysis of the effects of LRRK2-IN-1 and BMPPB-32 on
the TH.G2019S responses shown in Figure 8
Fig Parameter TH.G2019S versus
TH/+ (no drugs)
TH.G2019S
LRRK2-IN-1
versus no drug
BMPPB-32
versus no drug
8B 1F1 ∗ ∗ NS NS
2F1 ∗ ∗ NS
2F2 NS NS NS
2F1+2F2 ∗ ∗ ∗∗ NS
8C 1F1 phase ∗ ∗ ∗ ∗
8D 2F1 c50
∗ ∗ ∗ ∗∗∗ P ¼ 0.06
2F1 Rmax
∗ ∗ ∗ ∗∗∗ ∗∗
∗P, 0.05, ∗∗P, 0.01, ∗∗∗P , 0.001.
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constant until the point at which the mask and probe contrasts
were equal, then decaying rapidly (25). We also observed
robust second (1F1+2F1) and fourth (2F1+2F2) order non-
linear intermodulation terms that peaked when the probe and
mask were equal in contrast (30). These results suggest that
many of the computations involved in luminance and contrast
processing are conserved between the early stages of the
mammalian and Drosophila visual systems.
Figure 8.Kinase inhibitors targeted at LRRK2 restore normal responses in the presence of TH.G2019S at day 1. Data from four phenotypes are displayed: control
(TH/+), untreated TH.G2019S and TH.G2019S flies raised on food containing kinase inhibitor drugs LRRK2-IN-1 or BMPPB-32 at 2.5 mM concentrations.
(A) Contrast response functions for 2F1 show the increased signalling in TH.G2019S is reverted by LRRK2-IN-1 or BMPPB-32. (B) Average responses and
data spread measured at a single contrast and mask level for different frequency components. The 1F1 signals derive primarily from the photoreceptor responses
and are evaluated at 63% probe contrast. 2F1 signals are transient neuronal responses to the same input. 2F2 components derive from neuronal responses to the
mask in the presence of a very weak probe input (30%mask contrast, 7% probe contrast). The 2F1+2F2 intermodulation term is likely to arise from non-linear inter-
actions indeeperneuronal structures—hereweevaluate it at its peak,whichoccurswhen theprobeandmaskcontrasts are approximately equal (probe ¼ 35%contrast,
mask ¼ 30%contrast). At 1F1, 2F1 and 2F1+2F2, the presence of the hLRRK2-G2019S transgene elevates the response amplitude significantly (P , 0.05, Table 1).
Responses fromanimals raisedon2.5 mMLRRK2-IN-1are restoredand statistically indistinguishable from thoseof the controls.ThecompoundBMPPB-32at 2.5 mM
concentration also reduced the response amplitude at these frequencies, although the reduction only reached statistical significance in the intermodulation term
(2F1+2F2). The responses of G2019S flies are notably more variable across individuals than those of the other organisms. (C) Phase plots for unmasked 1F1,
showing that both LRRK2-IN-1 and BMPPB-32 restore control-level neuronal SSVEP responses phasesmeasured at 63%probe contrast. Error circles are computed
on the complex data using the t-circ statistic. (D) Estimated c50 values for each of the four phenotypes in (A), showing that the c50 value for TH.G2019S is approxi-
mately half that of thewild-typeoutcross (TH/+). Both kinase inhibitors restore thewild-typevalue. Statistical tests for the data shown in (B–D) are shown inTable 1.
(In B and D, the plots show mean, 95% confidence intervals and data range. n ¼ 10, 11, 12, 10.)
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We also note some differences between our results and those
from other organisms. While we observe strong masking of the
neuronal responses, this is best described by response gain
control (a reduction in the maximum firing rate) rather than the
contrast-gain control (a decrease in sensitivity) as observed in
other organisms (25,27,30). The reason for this is unclear. One
explanation may be that our response curves do not saturate—
possibly because we are using a zero-dimensional stimulus
that drives spatially tuned neurons only weakly. In addition,
our light source was monochromatic and short wavelength
which may have slowed the reconversion of metarhodopsin to
rhodopsin in the phototransduction cascade, thereby reducing
the overall temporal sensitivity of the preparation (47–49).
Without a saturating response, it is difficult to distinguish
changes in response gain from changes in contrast gain unam-
biguously and it is possible that both effects are present in our
data. Finally, our stimulus drove responses across much of the
visual field exciting essentially all neurons in the visual system
to some degree. It is possible that masking in Drosophila
depends on the spatial configuration and extent of stimuli as it
does in the human visual system (50,51) and that altering the
relative sizes of the excitatory and inhibitory stimulus compo-
nents can lead to a range of contrast response functions that en-
compass both response- and contrast-gain effects (42).
Effects of the PD-related LRRK2-G2019S
We find that expressing LRRK2-G2019S in the dopaminergic
neurons affects neural signalling in the retinal network at
day 1, and that this is manifest as an increase in sensitivity,
masking, intermodulation and shorter latency. These character-
istics suggest that visual neuronsmaybedepolarized, andunable
to maintain their resting membrane potential because they
cannot synthesize enough ATP to pump cations across the
plasmamembrane fast enough. Knockout of another PD-related
gene, parkin, also results in membrane depolarization (52).
Although losses of photoreceptor function and disorganization
in the regular lattice of ommatidia have been seen when
LRRK2 and other PD-related genes (e.g. a-synuclein) were
manipulated (9,53,54), the reason for this neurodegeneration
was unknown. Hindle et al. (9) showed that increasing neuronal
activity accelerated the loss of photoreceptor function, which
was associated with mitochondrial decay and possible problems
with ATP synthesis. Now our data provide support for the idea
that extra (unregulated) neuronal activity is an early step
towards neuronal degeneration.
In Drosophila larvae, the rate of transmitter release at the
neuromuscular junction was slowed by LRRK2-G2019S expres-
sion (16,17). Our data do not allow us to separate changes in
neuronal excitability from changes in transmitter release.
However, we note that exogenous dopamine slows the speed
of the isolated photoreceptor response (10), while visual re-
sponse negatively correlates with dopamine levels in the brain
(55). Thus, if LRRK2-G2019S expression in the dopaminergic
neurons reduces the release of dopamine, we would expect a
faster visual response. This is commensurate with our phase
data, which showed a decrease in latency of 10–13 ms at the
photoreceptors. A similar change in latency was inherited by
the second-order neurons.
However, there is a major difference between the previous
neuromuscular junction experiments (16,17); and our work in
theways inwhich LRRK2-G2019Swas expressed. Their record-
ings were made from synapses at which the transgene was
expressed both pre- and post-synaptically, but our biggest differ-
ence comes from neurons (in the lamina, medulla) in which
LRRK2-G2019S was not expressed. Rather the lamina and
Figure9.Off-target effects ofLRRK2kinase inhibitors.Thecontrast response functions (A) 2F1and (B) 2F2of thedLRRK2knockout are similar to thoseofwild-type
flies (TH/+). Application of 2.5 mMLRRK2-IN-1 produces amarked phenotype (increased amplitude, strongermask), while BMPPB-32 has no effect. This suggests
that LRRK2-IN-1 has an off-target effect, as the dLRRK2 knockout has no LRRK2 homolog. n ¼ 10, 18, 7, 8.
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medulla neurons surround the dopaminergic neurons in which
theG2019S transgenewas expressed. An impact on surrounding
neurons of expressing G2019S suggests non-autonomous
actions, as proposed by Braak et al. (56) and reported from
human and animal studies of another PD-related gene,
a-synuclein (57–59).
In-vivo testing of kinase function of LRRK2
A consistent feature of LRRK2-G2019S in biochemical assays is
elevated kinase activity compared with wild-type hLRRK2 (21).
Our day 1 visual data also show a marked difference between
TH.hLRRK2 and TH.G2019S, which is reduced by kinase
inhibitors LRRK2-IN-1 and BMPPB-32, suggesting that the
kinase function is crucial in thewhole organism aswell as in bio-
chemical and cell culture assays. The use of dLRRK2 flies, in
which no LRRK homolog is present, discriminates the two inhi-
bitors, BMPPB-32 and LRRK2-IN-1, with the latter providing
marked off-target effects.
A wide range of kinase inhibitors are being developed for in-
hibition of LRRK2 (60,61), but little testing has been done in the
whole organism. Two kinase inhibitors, GW5074 and sorafenib,
havebeen tested inDrosophila lifespan andclimbing assays, and
provided some extension of lifespan (62). Their median lifespan
was 12–13 weeks, making our fly assay much faster (,14 days
treatment, ,1 h recording/and analysis per fly).
Our SSVEP assay therefore provides a robust and stable plat-
form, with quantitative outputs that gives insights into basic
neuronal processing, mechanisms of gain control, suggesting
homology in retinal function between flies and mammals, and
can be used for assessing the effectiveness and selectivity of
drug development candidates.
MATERIALS AND METHODS
Fly stocks and genetics
Stock vials of Drosophila melanogaster were kept on yeast-
sucrose-agar fly food (63). The GAL4/UAS system was used for
targeted gene expression using theUAS-constructsUAS-hLRRK2
orUAS-G2019S (64), andTH-GAL4(44), toachieveexpression in
the dopaminergic neurons. For controls, we crossed TH-GAL4
with a white-eyed wild-type (w1118, herein +). These fly crosses
were used for direct comparison with our previous paper (9).
The dLRRK2 line, also known as e03680 (65,66), is a complete
knockout of the fly homolog to LRRK2. In developing the tech-
nique, we also used the histamine receptor A null ort2/2
(ortUS6096, also known as ort5) strain (33). As these flies have
white eyes, we compared their visual response with w1118 flies.
Experimental flies were kept in a 12 h light on:12 h off constant
temperature room (258C), and allowed to lay eggs on instant fly
food (Carolina Biological Supply). After 2 days, the adult flies
were removed. Vials were inspected daily, females collected and
the visual response was tested within 10–18 h of eclosion.
Preparation
Female flies were aspirated out of their vial into a shortened
pipette tip. Once the head emerged, each fly was secured with
a small droplet of nail polish (Creative Nail Design) (Fig. 1A)
and the fly was allowed to recover in the dark for ≏10 min.
The fly was illuminated by a blue light from an LED. The
intensity was controlled by a sequence generator encoded in
Matlab. In some parts of the sequence, we delivered a single
square wave, flickering about the mean illumination at a fre-
quency of 12 Hz. This stimulus we called the ‘probe’. In other
parts of the sequence, we delivered a wave made up of the sum
of two square waves, one at 12 Hz and the other at 15 Hz. In
this case we refer to the second, 15 Hz component as the
‘mask’. We used square waves to reflect the stimuli used in our
earlier drosophilaERGexperiments (9) andSSVEPexperiments
with human subjects (30). We placed a single electrode on the
surface of the Drosophila eye and recorded a single waveform
in response to each stimulus sequence. Each stimulus sweep
gave a signal well above the system noise, so that a phase-locked
response is evident (Fig. 1C). These time series were analysed in
the frequency domain using a Fourier transform from which the
scalar amplitude (Fig. 1D) and phase, or temporal ‘lag’ (Fig. 1E)
of individual frequency components was extracted (67). Full
details of the apparatus and recording method are presented in
Supplemental Material.
Kinase inhibitors
We tested the effect on fly vision of two potential LRRK2 kinase
inhibitors. One, BMPPB-32 is novel and fully characterized in
the Supplementary Material. There we report its synthesis, bio-
chemical and cellular properties, role as a kinase inhibitor and
uptake to the CNS. The second inhibitor is LRRK2-in-1 (Div-
isionofSignalTransductionTherapy (DSTT)Unit at theUniver-
sity of Dundee). Stock solutions in ethanol were kept at 2208C
until the day of use. The solution was diluted into de-ionized
water, and mixed with the Instant Fly Food compound, making
the final concentration 2.5 mM. Adults (8–10 female, 3–5
male flies) were allowed to lay eggs on the food for 2 days and
then removed. Larvae were allowed to develop into pupae, and
the emerging adults collected between 4 and 18 h.
SUPPLEMENTARYMATERIAL
Supplementary Material is available at HMG online.
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